Optimisation of a diagnostic model to predict the effectiveness of chemoradiotherapy for cervical cancer in a group of patients with comorbid conditions: cohort single-center retrospective study

Author:

Bashkirov L. V.1ORCID,Tonoyan N. M.1ORCID,Bergen T. A.1ORCID

Affiliation:

1. National Medical Research Center named after academician E. N. Meshalkin

Abstract

INTRODUCTION: Radiomics is a promising area of diagnostics. In clinical practice, ultrasound and magnetic resonance imaging are widely used for Cervical Cancer (CC). The lack of standards when carrying out examinations entails the problem of distinguishing different signs, i.e. there is no possibility to compare results of different institutions.OBJECTIVE: To review radiological diagnostic procedures and optimize a model to enable expanded large-scale multicentre mathematical analysis of radiological findings in comorbid women with CC.MATERIALS AND METHODS: The data from 362 magnetic resonance imaging (MRI) procedures (Philips Achieva, The Netherlands, 1.5T), 500 pelvic ultrasound procedures (US), and 500 retroperitoneal US in 77 comorbid women with cervical squamous cell cancer and cardiovascular disease, carried out between 2012 and 2022, were retrospectively examined. FIGO pretreatment stage 1А–4А. Age: 48.3±13.1. Follow-up period: 3.7±1.3 years.Statistics: Data analysis was carried out using the Stata 13 program (StataCorpLP, CollegeStation, TX, USA). The normality of the distribution of features was assessed using the Shapiro-Wilk criterion. The condition of equality of variances of the distribution of features was calculated according to the Leven criterion. For descriptive statistics of normally distributed features with equality of variances, the calculation of averages and standard deviations was used. Qualitative variables are represented as numbers (%). Logistic regression is performed. The significance level for all the methods used is set as p<0.05.RESULTS: The possibility of segmentation was 2.6% according to US and 100% according to MRI. We analyzed 1443 T2 TSE, 531 T1 TSE, 563 diffusion-weighted images (DWI), 389 STIR, 1987 post-contrast series (in 272 cases (75%) the study was accompanied by contrast agent administration). An MRI model for subsequent feature extraction in patients with CC should consist of T2TSE in the sagittal plane, DWI in the axial plane with automatic construction of apparent diffusion coefficient (ADC) maps.The most reproducible and valuable components of the model are found to be the DWI with automatic ADC map. The ADC value from the parametral fat significantly increased the probability of recurrence, and the cut-off point for ROC analysis was 1.1×10–3 mm2/sec.DISCUSSION: An analysis of medical ultrasound and MRI images in terms of their value for radiomics was carried out. According to the results, MRI is the preferred method. An important next step is to standardize series to extract additional value from diagnostic studies and to carry out multicentre retrospective studies using a multicomponent model.CONCLUSIONS: MRI is a reproducible and frequently used method with the ability to extract additional value from images. T2 TSE in the sagittal plane and DWI in the axial plane with automatic ADC map, followed by segmentation of the parametral area adjacent to the tumor, are considered the most frequently used techniques. Postcontrast imaging are not a reproducible technique and have no added value. A model MRI procedure to determine additional textural characteristics in patients with СС consists of T2-TSE in the sagittal plane, DWI in the axial plane with automatic ADC map.

Publisher

Baltic Medical Education Center

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3